A study design to investigate the effect of short-form Sun-style Tai Chi in improving functional exercise capacity, physical performance, balance and health related quality of life in people with Chronic Obstructive Pulmonary Disease (COPD).

scientific article published on 13 November 2010

A study design to investigate the effect of short-form Sun-style Tai Chi in improving functional exercise capacity, physical performance, balance and health related quality of life in people with Chronic Obstructive Pulmonary Disease (COPD). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CCT.2010.11.006
P698PubMed publication ID21078418
P5875ResearchGate publication ID47793772

P50authorZoe J. McKeoughQ45927733
Matthew J. PetersQ51728931
P2093author name stringJ A Alison
R W M Leung
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
quality of lifeQ13100823
P304page(s)267-272
P577publication date2010-11-13
P1433published inContemporary Clinical TrialsQ5164971
P1476titleA study design to investigate the effect of short-form Sun-style Tai Chi in improving functional exercise capacity, physical performance, balance and health related quality of life in people with Chronic Obstructive Pulmonary Disease (COPD)
P478volume32

Reverse relations

cites work (P2860)
Q34502113Effects of Tai Chi on exercise capacity and health-related quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Q97645813Effects of the tai chi qigong programme on functional capacity, and lung function in chronic obstructive pulmonary disease patients: A ramdomised controlled trial
Q27025647Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials
Q24202338Tai Chi for chronic obstructive pulmonary disease (COPD)
Q26471513Tai Chi for chronic obstructive pulmonary disease (COPD)
Q53682262The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation.

Search more.